GlassScriptPhysician profile
Harin Rajeev
NPI 1770623548
$6,159.84
in general payments reported to CMS, 2019-2025
15 companies · $999 in 2025
The $999 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $330 · 2021: $700 · 2022: $924 · 2023: $2,225 · 2024: $523 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Travel and Lodging: $733 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,006.52 |
| Travel and Lodging | $733.21 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,080.69 | 2021-2025 | Acuvue |
| Alcon Vision LLC | $1,545.05 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Bausch & Lomb Americas INC. | $1,075.66 | 2022-2025 | Infuse, Alden Scleral Zenlens, Biotrue |
| Sun Pharmaceutical Industries INC. | $386.39 | 2020-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $364.69 | 2019-2021 | |
| Coopervision INC. | $263.66 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Oyster Point Pharma, INC. | $110.12 | 2023 | Tyrvaya |
| Sight Sciences, INC. | $72.53 | 2022-2023 | Tearcare System |
| Visioneering Technologies, INC. | $68.67 | 2020 | |
| Abb Con-Cise Optical Group LLC | $55.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.21 | 2021 | |
| Maculogix, INC. | $39.05 | 2020-2021 | |
| Allergan, INC. | $26.22 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $17.18 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harin Rajeev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.